Literature DB >> 29744218

Machine perfusion of thoracic organs.

Dirk Van Raemdonck1,2, Filip Rega3,4, Steffen Rex4,5, Arne Neyrinck4,5.   

Abstract

This article summarizes recent knowledge and clinical advances in machine perfusion (MP) of thoracic organs. MP of thoracic organs has gained much attention during the last decade. Clinical studies are investigating the role of MP to preserve, resuscitate, and assess heart and lungs prior to transplantation. Currently, MP of the cardiac allograft is essential in all type DCD heart transplantation while MP of the pulmonary allograft is mandatory in uncontrolled DCD lung transplantation. MP of thoracic organs also offers an exciting platform to further investigate downregulation of the innate and adaptive immunity prior to reperfusion of the allograft in recipients. MP provides a promising technology that allows pre-transplant preservation, resuscitation, assessment, repair, and conditioning of cardiac and pulmonary allografts outside the body in a near physiologic state prior to planned transplantation. Results of ongoing clinical trials are awaited to estimate the true clinical value of this new technology in advancing the field of heart and lung transplantation by increasing the total number and the quality of available organs and by further improving recipient early and long-term outcome.

Entities:  

Keywords:  Heart transplantation; donor after circulatory death; ex vivo lung perfusion (EVLP); lung transplantation; machine perfusion (MP)

Year:  2018        PMID: 29744218      PMCID: PMC5934115          DOI: 10.21037/jtd.2018.02.85

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  155 in total

Review 1.  Advances in lung preservation.

Authors:  Tiago N Machuca; Marcelo Cypel; Shaf Keshavjee
Journal:  Surg Clin North Am       Date:  2013-10-17       Impact factor: 2.741

2.  Normothermic ex vivo lung perfusion in clinical lung transplantation.

Authors:  Marcelo Cypel; Jonathan C Yeung; Mingyao Liu; Masaki Anraku; Fengshi Chen; Wojtek Karolak; Masaaki Sato; Jane Laratta; Sassan Azad; Mindy Madonik; Chung-Wai Chow; Cecilia Chaparro; Michael Hutcheon; Lianne G Singer; Arthur S Slutsky; Kazuhiro Yasufuku; Marc de Perrot; Andrew F Pierre; Thomas K Waddell; Shaf Keshavjee
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

3.  A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death.

Authors:  Christopher W White; Ayyaz Ali; Devin Hasanally; Bo Xiang; Yun Li; Paul Mundt; Matthew Lytwyn; Simon Colah; Julianne Klein; Amir Ravandi; Rakesh C Arora; Trevor W Lee; Larry Hryshko; Stephen Large; Ganghong Tian; Darren H Freed
Journal:  J Heart Lung Transplant       Date:  2013-07       Impact factor: 10.247

Review 4.  Donation after circulatory death heart transplantation.

Authors:  Kumud K Dhital; Hong C Chew; Peter S Macdonald
Journal:  Curr Opin Organ Transplant       Date:  2017-06       Impact factor: 2.640

5.  Preemptive therapy with steroids but not macrolides improves gas exchange in caustic-injured donor lungs.

Authors:  Caroline M Meers; Shana Wauters; Eric Verbeken; Hans Scheers; Bart Vanaudenaerde; Geert M Verleden; Dirk Van Raemdonck
Journal:  J Surg Res       Date:  2011-06-25       Impact factor: 2.192

6.  Functional assessment and transplantation of the donor heart after circulatory death.

Authors:  Simon J Messer; Richard G Axell; Simon Colah; Paul A White; Marian Ryan; Aravinda A Page; Barbora Parizkova; Kamen Valchanov; Christopher W White; Darren H Freed; Euan Ashley; John Dunning; Martin Goddard; Jayan Parameshwar; Christopher J Watson; Thomas Krieg; Ayyaz Ali; Steven Tsui; Stephen R Large
Journal:  J Heart Lung Transplant       Date:  2016-07-16       Impact factor: 10.247

7.  Preservation of isolated heart for 72 hours.

Authors:  E Proctor; R Parker
Journal:  Br Med J       Date:  1968-11-02

8.  Low-flow perfusion of guinea pig isolated hearts with 26 degrees C air-saturated Lifor solution for 20 hours preserves function and metabolism.

Authors:  David F Stowe; Amadou K S Camara; James S Heisner; Mohammed Aldakkak; David R Harder
Journal:  J Heart Lung Transplant       Date:  2008-07-26       Impact factor: 10.247

9.  Physiologic Changes in the Heart Following Cessation of Mechanical Ventilation in a Porcine Model of Donation After Circulatory Death: Implications for Cardiac Transplantation.

Authors:  C W White; R Lillico; J Sandha; D Hasanally; F Wang; E Ambrose; A Müller; O Rachid; Y Li; B Xiang; H Le; S Messer; A Ali; S R Large; T W Lee; I M C Dixon; T M Lakowski; K Simons; R C Arora; G Tian; J Nagendran; L V Hryshko; D H Freed
Journal:  Am J Transplant       Date:  2015-12-11       Impact factor: 8.086

10.  The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.

Authors:  Anders S I Andreasson; Lee A Borthwick; Colin Gillespie; Kasim Jiwa; Jonathan Scott; Paul Henderson; Jonny Mayes; Rosalba Romano; Marius Roman; Simi Ali; James E Fildes; Nandor Marczin; John H Dark; Andrew J Fisher
Journal:  J Heart Lung Transplant       Date:  2017-05-12       Impact factor: 10.247

View more
  12 in total

Review 1.  Ex vivo lung perfusion prior to transplantation: an overview of current clinical practice worldwide.

Authors:  Julien Possoz; Arne Neyrinck; Dirk Van Raemdonck
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 2.  The donor heart and organ perfusion technology.

Authors:  Hong Chee Chew; Peter S Macdonald; Kumud K Dhital
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 3.  Bioengineering approaches to organ preservation ex vivo.

Authors:  Meghan Pinezich; Gordana Vunjak-Novakovic
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-19

Review 4.  Optimizing organs for transplantation; advancements in perfusion and preservation methods.

Authors:  Elizabeth Soo; Christopher Marsh; Robert Steiner; Lisa Stocks; Dianne B McKay
Journal:  Transplant Rev (Orlando)       Date:  2019-10-17       Impact factor: 3.943

Review 5.  Complement Therapeutics in the Multi-Organ Donor: Do or Don't?

Authors:  Judith E van Zanden; Neeltina M Jager; Mohamed R Daha; Michiel E Erasmus; Henri G D Leuvenink; Marc A Seelen
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

Review 6.  Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.

Authors:  Thomas Resch; Benno Cardini; Rupert Oberhuber; Annemarie Weissenbacher; Julia Dumfarth; Christoph Krapf; Claudia Boesmueller; Dietmar Oefner; Michael Grimm; Sefan Schneeberger
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

7.  Expanding controlled donation after the circulatory determination of death: statement from an international collaborative.

Authors:  Beatriz Domínguez-Gil; Nancy Ascher; Alexander M Capron; Dale Gardiner; Alexander R Manara; James L Bernat; Eduardo Miñambres; Jeffrey M Singh; Robert J Porte; James F Markmann; Kumud Dhital; Didier Ledoux; Constantino Fondevila; Sarah Hosgood; Dirk Van Raemdonck; Shaf Keshavjee; James Dubois; Andrew McGee; Galen V Henderson; Alexandra K Glazier; Stefan G Tullius; Sam D Shemie; Francis L Delmonico
Journal:  Intensive Care Med       Date:  2021-02-26       Impact factor: 17.440

8.  Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex vivo Organ Perfusion.

Authors:  Yuliia Yuzefovych; Emilio Valdivia; Song Rong; Franziska Hack; Tamina Rother; Jessica Schmitz; Jan Hinrich Bräsen; Dirk Wedekind; Cyril Moers; Nadine Wenzel; Faikah Gueler; Rainer Blasczyk; Constanca Figueiredo
Journal:  Front Immunol       Date:  2020-02-19       Impact factor: 7.561

Review 9.  Isolated Lung Perfusion in the Management of Acute Respiratory Distress Syndrome.

Authors:  Nathan Haywood; Matthew R Byler; Aimee Zhang; Mark E Roeser; Irving L Kron; Victor E Laubach
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

10.  Subnormothermic ex vivo lung perfusion attenuates ischemia reperfusion injury from donation after circulatory death donors.

Authors:  Stephan Arni; Tatsuo Maeyashiki; Isabelle Opitz; Ilhan Inci
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.